PHASE SEPARATION LIQUID-LIQUID EXTRACTION FOR THE QUANTIFICATION OF 8-ISO-PROSTAGLANDIN F2 ALPHA IN HUMAN PLASMA BY LC-MS/MS
Abstract
Summary
Background. Reactive oxygen species (ROS) are produced in the body during normal metabolism by means of enzymes and non-enzymatic chemical reduction of molecular oxygen. In case of prevalence of ROS formation over their elimination, highly reactive free radicals can be accumulated and can cause multiple damages to the biomolecules and cells. Determination of isoprostanes in biological matrices is most often used to register free radical damage and requires selective, sensitive and specific techniques. Methods. This study presents the development and validation of an LC-MS/MS method for the determination of 8-iso-Prostaglandin F2α in human plasma utilising a modified liquid-liquid extraction procedure with phase separation. Results. Modified sample preparation procedure assured higher extraction yield, clear separation of organic layer from plasma water phase and protein precipitates, and better purified product for instrumental analysis. Linearity was validated in the range 0.1 – 5.0 µg/L with R2>0.996; normalised matrix varied between 86.0 and 108.3%, accuracy ranged from 90.4 % to 113.9% and precision both within-runs and between-runs was less than 7%. With a run time of 10 min, a throughput of over 50 samples per working day could be performed. Conclusion. The method meets all the current industrial validation criteria and allows the accurate and precise determination of 8-iso-PGF2α in human plasma at diagnostically significant concentration range.References
Saeidnia S, Abdollahi M. Toxicological and pharmacological concerns on oxidative stress and related diseases. Toxicol Appl Pharmacol 2013; 273(3): 442-55.
Marrocco I, Altieri F, Peluso I. Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans. Oxid Med Cell Longev 2017; 2017: 6501046.
Cipak Gasparovic A, Zarkovic N, Zarkovic K, Semen K, Kaminskyy D, Yelisyeyeva O et al. Biomarkers of oxidative and nitro-oxidative stress: conventional and novel approaches. Br J Pharmacol 2017; 174(12): 1771-83.
Comporti M, Signorini C, Arezzini B, Vecchio D, Monaco B, Gardi C. F2-isoprostanes are not just markers of oxidative stress. Free Radic Biol Med 2008; 44(3): 247-56.
Roberts LJ, Morrow JD. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28(4): 505-13.
Milne GL, Sanchez SC, Musiek ES, Morrow JD. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc 2007; 2(1): 221-6.
Catalá A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids 2009; 157(1): 1-11.
Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 2009; 47(5): 469-84.
Davies SS, Guo L. Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids. Chem Phys Lipids 2014; 181: 1-33.
Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci 1990; 87(23): 9383-7.
Morrow JD, Chen Y, Brame CJ, Yang J, Sanchez SC, Xu J, et al. The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. Drug Metab Rev 1999; 31(1): 117-39.
Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006; 52(4): 601-23.
Giustarini D, Dalle-Donne I, Tsikas D, Rossi R. Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 2009; 46(5-6): 241-81.
Galano JM, Mas E, Barden A, Mori TA, Signorini C, De Felice C et al. Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans. Prostaglandins Other Lipid Mediat 2013; 107: 95-102.
Basu S. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal. 2008; 10(8): 1405-34.
Noble S, Neville D, Houghton R. Determination of 8-iso-prostaglandin F2α (8-iso-PGF(2α)) in human urine by ultra-performance liquid chromatography – tandem mass spectrometry. J Chromatogr B, Anal Technol Biomed Life Sci 2014; 947-948: 173-8.
Milne GL, Gao B, Terry ES, Zackert WE, Sanchez SC. Measurement of F2-isoprostanes and isofurans using gas chromatography–mass spectrometry. Free Radic Biol Med 2013; 59: 36-44.
Janicka M, Kubica P, Kot-Wasik A, Kot J, Namieśnik J. Sensitive determination of isoprostanes in exhaled breath condensate samples with use of liquid chromatography–tandem mass spectrometry. J Chromatogr B, Anal Technol Biomed Life Sci 2012; 893-894: 144-9.
Syslová K, Kacer P, Kuzma M, Klusácková P, Fenclová Z, Lebedová J et al. Determination of 8-iso-prostaglandin F(2alpha) in exhaled breath condensate using combination of immunoseparation and LC-ESI-MS/MS. J Chromatogr B, Anal Technol Biomed Life Sci 2008; 867(1): 8-14.
Milne GL, Dai Q, Roberts LJ 2nd. The isoprostanes-25 years later. Biochim Biophys Acta 2015; 1851(4): 433-45.
Chhonker YS, Bala V, Murry DJ. Quantification of eicosanoids and their metabolites in biological matrices: a review. Bioanalysis 2018; 10(24): 2027-46.
Dreissigacker U, Suchy MT, Maassen N, Tsikas D. Human plasma concentrations of malondialdehyde (MDA) and the F2-isoprostane 15(S)-8-iso-PGF(2alpha) maybe markedly compromised by hemolysis: evidence by GC-MS/MS and potential analytical and biological ramifications. Clin Biochem 2010; 43(1-2): 159-67.
Thakare R, Chhonker YS, Gautam N, Nelson A, Casaburi R, Criner G et al. Simultaneous LC-MS/MS analysis of eicosanoids and related metabolites in human serum, sputum and BALF. Biomed Chromatogr 2018; 32(3).
Smith KA, Shepherd J, Wakil A, Kilpatrick ES. A comparison of methods for the measurement of 8-isoPGF(2α): a marker of oxidative stress. Ann Clin Biochem 2011; 48(Pt 2): 147-54.
Wiswedel I. F2-isoprostanes: sensitive biomarkers of oxidative stress in vitro and in vivo: a gas chromatography–mass spectrometric approach. Methods Mol Biol 2009; 580: 3-16.
Kortz L, Dorow J, Ceglarek U. Liquid chromatography–tandem mass spectrometry for the analysis of eicosanoids and related lipids in human biological matrices: a review. J Chromatogr B, Anal Technol Biomed Life Sci 2014; 964: 1-11.
Tsikas D, Zoerner AA. Analysis of eicosanoids by LC-MS/MS and GC-MS/MS: a historical retrospect and a discussion. J Chromatogr B, Anal Technol Biomed Life Sci 2014; 964: 79-88.
Puppolo M, Varma D, Jansen SA. A review of analytical methods for eicosanoids in brain tissue. J Chromatogr B, Anal Technol Biomed Life Sci 2014; 964: 50-64.
Willenberg I, Ostermann AI, Schebb NH. Targeted metabolomics of the arachidonic acid cascade: current state and challenges of LC-MS analysis of oxylipins. Anal Bioanal Chem 2015; 407(10): 2675-83.
European Medicines Agency. Guideline on bioanalytical method validation. EMEA/CHMP/EWP/192217/2009 2009. www.ema.europa.eu
USA FDA. Guidance for Industry: bioanalytical method validation. FDA-2013-D-1020 2018. www.fda.gov
Copyright (c) 2020 Desislav Tomov, Georgeta Bocheva, Vidka Divarova, Lilia Kasabova, Dobrin Svinarov
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.